US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 5.4000
  • +0.5600+11.57%
Close Jul 24 16:00 ET
  • 5.3000
  • -0.1000-1.85%
Post 18:17 ET
48.16MMarket Cap-8437P/E (TTM)

Marker Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Marker Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.24M

+0.79%
EPS(YoY)

-0.27

+52.63%
Analyst Rating

Buy

Jun 30, 2024

Marker Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q11.244M / 0.000--
--2022/Q43.309M / 0.000--
--2022/Q33.950M / 266.670K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q11.244M / 0.000--
--2022/Q43.309M / 0.000--
--2022/Q33.950M / 266.670K--

Unlock Free Earnings Estimates

Marker Therapeutics Earnings Reports

  • Marker Therapeutics | 10-Q: Quarterly report

    May 15 16:06 ET

  • Marker Therapeutics | 10-K: Annual report

    Mar 26 13:28 ET

  • Marker Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:31 ET

  • Marker Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg